Anti-VEGF Therapy Versus Dexamethasone Implant for DME

Summary

We look at a randomized comparative study of 2 FDA approved anti-VEGF agents(aflibercept and ranibizumab) and see how they compare against the dexamethasone implant for phakic as well as pseudophakic eyes with treatment naive diabetic macular edema in terms of efficacy and safety over two years.

Timeline

Start

2019-06-25

Primary completion

2021-06-24

Completion

2023-06-24

Drugs

Indications